APA

Ghamlouch H., Ouled-Haddou H., Guyart A., Regnier A., Trudel S., Claisse J., Fuentes V., Royer B., Marolleau J. & Gubler B. (20140701). TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells. : Frontiers in immunology.

Chicago

Ghamlouch Hussein, Ouled-Haddou Hakim, Guyart Aude, Regnier Aline, Trudel Stéphanie, Claisse Jean-François, Fuentes Vincent, Royer Bruno, Marolleau Jean-Pierre and Gubler Brigitte. 20140701. TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells. : Frontiers in immunology.

Harvard

Ghamlouch H., Ouled-Haddou H., Guyart A., Regnier A., Trudel S., Claisse J., Fuentes V., Royer B., Marolleau J. and Gubler B. (20140701). TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells. : Frontiers in immunology.

MLA

Ghamlouch Hussein, Ouled-Haddou Hakim, Guyart Aude, Regnier Aline, Trudel Stéphanie, Claisse Jean-François, Fuentes Vincent, Royer Bruno, Marolleau Jean-Pierre and Gubler Brigitte. TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells. : Frontiers in immunology. 20140701.